The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Optically Clear, Highly Flexible Epoxy Cures at Room Temperature

March 25, 2011 7:19 am | Master Bond, Inc. | Product Releases | Comments

For demanding applications where highly flexible, impact resistant bonds are required, Master Bond developed Polymer System EP37-3FLF.

Digital Force Gauge Series

March 25, 2011 7:11 am | Product Releases | Comments

Mark-10 introduces its Series 3 digital force gauges, designed for tension and compression force testing in quality control, manufacturing, and R&D areas.

Self-Retaining T-1 LED Mounting Spacers

March 25, 2011 7:07 am | Keystone Electronics Corp. | Product Releases | Comments

A series of self-retaining, T-1 LED mounting spacers designed to ensure uniform and perpendicular LED positioning while reducing assembly costs is now available from Keystone Electronics Corp.


Digitally Programmable 1,200 Watt DC-input Bulk Front-End Power Supply

March 25, 2011 7:03 am | Product Releases | Comments

Emerson Network Power has launched the DS1200DC-3, a high-efficiency DC-input 1,200 watt bulk front-end power supply for systems that use distributed power architectures.

CVS Caremark Research Finds "Dispense as Written" Prescriptions May Add $7.7 Billion to Annual Health Care Costs

March 25, 2011 6:36 am | by Bio-Medicine.Org | News | Comments

WOONSOCKET, R.I., March 25, 2011 /- Approximately five percent of prescriptions submitted by CVS Caremark Pharmacy Benefit Management (PBM) members in a 30-day period during 2009 included a "dispense as written" (DAW) designation. This practice – whereby doctors or patients demand...


Sinovac Participates in UBS Greater China Healthcare Corporate Day

March 25, 2011 6:36 am | by Bio-Medicine.Org | News | Comments

BEIJING, March 25, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA ), a leading provider of biopharmaceutical products in China, announced today that Dr. Weidong Yin, President and CEO, and Ms. Helen Yang, Investor Relations Manager, are scheduled to participate in the UBS...


Watson Confirms District Court Ruling in Generic Fentora® Patent Suit

March 25, 2011 6:36 am | by Bio-Medicine.Org | News | Comments

MORRISTOWN, N.J., March 25, 2011 /- Watson Pharmaceuticals, Inc. (NYSE: WPI ), today confirmed that the United States District Court for the District of Delaware has ruled that Watson's generic version of Fentora® (fentanyl buccal tablets C-II) infringes United States Patent No....


Bellicum Pharmaceuticals Awarded $5.7 Million by the Cancer Prevention and Research Institute of Texas

March 25, 2011 6:36 am | by Bio-Medicine.Org | News | Comments

HOUSTON, March 25, 2011 /- Bellicum Pharmaceuticals, Inc. today announced that the Company received notice of a $5.7 million company commercialization award from the Cancer Prevention and Research Institute of Texas ("CPRIT"). Bellicum was the only company recommended for funding in this...


Heyltex Corporation Working With United States and Japan to Add Production of Radiological Antidotes

March 25, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

KATY, Texas, March 25, 2011 /PRNewswire-USNewswire/ -- Heyltex Corporation is the exclusive U.S. distributor of Radiogardase® (Prussian Blue insoluble capsules), the only FDA-approved drug to treat people who have been internally contaminated with radioactive cesium (Cs-137), which...


Mersana Therapeutics Initiates Phase 1b Extension Study of XMT-1001 in Gastric Cancer and Non-Small Cell Lung Cancer

March 25, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

CAMBRIDGE, Mass., March 25, 2011 /- Mersana Therapeutics today announced  the initiation of a Phase 1b extension study with its lead cancer product, XMT-1001 , a novel DNA topoisomerase I inhibitor based on the company's Fleximer® polymer conjugate platform, in second-line...


$2 Million Awarded to Duke University Prevention Epicenter to Study Reduction of Healthcare-Associated Infections Using Tru-D, Total Room Ultraviolet Disinfection

March 25, 2011 5:37 am | by Bio-Medicine.Org | News | Comments

DURHAM, N.C., March 25, 2011 /- Centers for Disease Control and Prevention has awarded $2 million to Duke University Prevention Epicenter as part of its program to conduct innovative research in the science of preventing Healthcare-Associated Infections, or HAIs, with the goal of saving...


AssureRx Health Raises $11 Million Series B Financing

March 25, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

CINCINNATI, March 25, 2011 /- AssureRx Health, Inc. today announced the closing of an $11 million Series B financing. The personalized medicine company, which provides clinically-relevant information to help physicians select the right drug and the right dose for individual...


Covaris Introduces Bench-top, AFA-based Process Technology

March 25, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

WOBURN, Mass., March 25, 2011 /- Covaris Incorporated today announced the introduction of the Bench-top SF220 High Performance Formulation Processing System. The SF220 system was designed to extend the company's ground-breaking Adaptive Focused Acoustics (AFA) technology to higher volume...


Aetna sues 6 NJ doctors for overbilling

March 25, 2011 2:45 am | by The Associated Press | News | Comments

Aetna Inc. is suing six New Jersey physicians, claiming they filed "unlawful and excessive" bills, including nearly $57,000 for a 25-minute consultation.The lawsuits stem from hospital care where patients were referred to in-network hospitals but received care from out-of-network physicians....

Inadequate diet can lead to anemia in postmenopausal women

March 24, 2011 9:38 pm | by EurekAlert | News | Comments

(Elsevier Health Sciences) A new study published in the April 2011 issue of the Journal of the American Dietetic Association indicates that inadequate nutrition is linked to a greater risk of anemia in postmenopausal women.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.